Roseanna E. Greenlaw - Publications

Collectin-11 regulates osteoclastogenesis and bone maintenance via a complement-dependent mechanism.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 03, 2026

Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 24, 2025

Multicentre, multi-arm, double-blind randomised placebo-controlled dose-finding trial investigating the safety and Efficacy of MirococePt (APT070) In Reducing delayed graft function In the Kidney ALlograft (EMPIRIKAL-2): study protocol for a randomised controlled trial.

Journal: BMJ open

Published: March 06, 2025

Ex vivo delivery of Mirococept: A dose-finding study in pig kidney after showing a low dose is insufficient to reduce delayed graft function in human kidney.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 31, 2020

Rationale for targeting complement in COVID-19.

Journal: EMBO molecular medicine

Published: April 30, 2020

Effects of multiple-dose ponesimod, a selective S1P1 receptor modulator, on lymphocyte subsets in healthy humans.

Journal: Drug design, development and therapy

Published: January 18, 2017

A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.

Journal: Trials

Published: December 02, 2016

HES1 in immunity and cancer.

Journal: Cytokine & growth factor reviews

Published: February 20, 2016

Thrombalexins: Cell-Localized Inhibition of Thrombin and Its Effects in a Model of High-Risk Renal Transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 14, 2015

FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells.

Journal: PloS one

Published: October 22, 2013

Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice.

Journal: Clinical and experimental immunology

Published: October 09, 2012

Role of the Fc region in CD70-specific antibody effects on cardiac transplant survival.

Journal: Transplantation

Published: November 18, 2011